MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Stacy Roughan
Stacy RoughanQUINCE THERAPEUTICS

Stacy Roughan

Vice President, Corporate Communications & Investor Relations at QUINCE THERAPEUTICS

Manager

Deal Bio

Total Deals1
Valued Deals1
Total Value£ 419 M
Avg. Deal Size£ 419 M

Market Context

Sort

24 Jul 2023|Italy|Biotechnology
ERYDEL
Quince Therapeutics

Target: ERYDEL

Bidder: QUINCE THERAPEUTICS

11 Service Providers

5 Target | 6 Bidder

74 Dealmakers

36 Target | 38 Bidder

£ 419 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Stacy Roughan